Cargando…

Genetic and clinical characterization of B7‐H3 (CD276) expression and epigenetic regulation in diffuse brain glioma

Gliomas are the most common malignant tumors of the brain. Immune checkpoints have been increasingly emphasized as targets for treating malignant tumors. B7‐H3 has been identified as an immune checkpoint that shows potential value for targeting therapies. We set out to characterize the expression pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhiliang, Wang, Zheng, Zhang, Chuanbao, Liu, Xing, Li, Guanzhang, Liu, Shuai, Sun, Lihua, Liang, Jingshan, Hu, Huimin, Liu, Yanwei, Zhang, Wei, Jiang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125452/ https://www.ncbi.nlm.nih.gov/pubmed/30027617 http://dx.doi.org/10.1111/cas.13744

Ejemplares similares

Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma
por: Wang, Zheng, et al.
Publicado: (2016)

MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status
por: Li, Guanzhang, et al.
Publicado: (2018)

FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients
por: Wang, Zheng, et al.
Publicado: (2016)

Comprehensive Analysis of the Clinical and Biological Significances of Endoplasmic Reticulum Stress in Diffuse Gliomas
por: Huang, Ruoyu, et al.
Publicado: (2021)

Corrigendum: Comprehensive analysis of the clinical and biological significances of endoplasmic reticulum stress in diffuse gliomas
por: Huang, Ruoyu, et al.
Publicado: (2022)

Comparative profiling of immune genes improves the prognoses of lower grade gliomas
por: Wang, Zhiliang, et al.
Publicado: (2022)

Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling
por: Wang, Qiangwei, et al.
Publicado: (2018)

CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high-grade glioma
por: Wang, Kuanyu, et al.
Publicado: (2018)

New-Onset Postoperative Seizures in Patients With Diffuse Gliomas: A Risk Assessment Analysis
por: Li, Lianwang, et al.
Publicado: (2021)

RGS16 promotes glioma progression and serves as a prognostic factor
por: Huang, Ruoyu, et al.
Publicado: (2020)

The Role of CD276 in Cancers
por: Liu, Shengzhuo, et al.
Publicado: (2021)

WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System
por: Zhao, Zheng, et al.
Publicado: (2022)

Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy
por: Wang, Kuanyu, et al.
Publicado: (2019)

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016)

High-dose radiation associated with improved survival in IDH-wildtype low-grade glioma
por: Liu, Shuai, et al.
Publicado: (2021)

Identification of an ATP metabolism‐related signature associated with prognosis and immune microenvironment in gliomas
por: Huang, Ruoyu, et al.
Publicado: (2020)

Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma
por: Wu, Fan, et al.
Publicado: (2018)

PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma
por: Wang, Meng-Yao, et al.
Publicado: (2021)

Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma
por: Liang, Jiayu, et al.
Publicado: (2020)

Correction: PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma
por: Wang, Meng-Yao, et al.
Publicado: (2021)

Correction: PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma
por: Wang, Meng-Yao, et al.
Publicado: (2023)

B7-H3/CD276: An Emerging Cancer Immunotherapy
por: Zhou, Wu-Tong, et al.
Publicado: (2021)

ISG20 promotes local tumor immunity and contributes to poor survival in human glioma
por: Gao, Mengqi, et al.
Publicado: (2018)

T-Cell Exhaustion Status Under High and Low Levels of Hypoxia-Inducible Factor 1α Expression in Glioma
por: Liu, Shuai, et al.
Publicado: (2021)

Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas
por: Liu, Yanwei, et al.
Publicado: (2021)

High‐sensitive clinical diagnostic method for PTPRZ1‐MET and the characteristic protein structure contributing to ligand‐independent MET activation
por: Huang, Ruoyu, et al.
Publicado: (2021)

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples
por: Di, Wang, et al.
Publicado: (2021)

Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients
por: Zhao, Zheng, et al.
Publicado: (2021)

Radiotherapy delays malignant transformation and prolongs survival in patients with IDH-mutant gliomas
por: Liu, Yanwei, et al.
Publicado: (2022)

Novel insights into the epigenetics of diffuse glioma
por: Danussi, Carla, et al.
Publicado: (2018)

Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
por: Inamura, Kentaro, et al.
Publicado: (2018)

ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors
por: Cai, Jinquan, et al.
Publicado: (2016)

High expression of cluster of differentiation 276 indicates poor prognosis in glioma
por: Li, Linchen, et al.
Publicado: (2021)

A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression
por: Zhou, Kaijia, et al.
Publicado: (2020)

HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival
por: Wu, Zhifeng, et al.
Publicado: (2020)

Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
por: Zhang, Kenan, et al.
Publicado: (2022)

ABCC8 mRNA expression is an independent prognostic factor for glioma and can predict chemosensitivity
por: Zhou, Kaijia, et al.
Publicado: (2020)

Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
por: Zhang, Kenan, et al.
Publicado: (2023)

Diffuse midline glioma treated with epigenetic agent-based immunotherapy
por: Jing, Linkai, et al.
Publicado: (2023)

Comprehensive Analysis Reveals Distinct Immunological and Prognostic Characteristics of CD276/B7-H3 in Pan-Cancer
por: Ding, Jinye, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g34kcij588j06vckhccnd3g095